ANTIKÖRPER GEGEN OPGL

Patent europeic · EP2087908 · Stritgà

Inscripziun en il register

Numer da publicaziun
EP2087908
Numer da la dumonda
EP09156995
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
Stritgà
Scrittira da patent
Concedì
Annunzià
25-06-2002
Publitgà
12-08-2009
Concedì
30-05-2018
Stritgà
01-07-2022
Motiv
Durada maximala cuntanschida
Classas IPC
A61K 39/395 (2006.01)
G01N 33/53 (2006.01)
C07K 16/28 (2006.01)
Prioritad
US 301172 P 26.06.2001
Derivà da
EP02749660
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 01-07-2022

    Durada maximala cuntanschida

    Published in Swissreg on 01.07.2022

  2. 22-09-2021

    Transferì

    Owner
    Amgen Inc., One Amgen Center Drive, Thousand Oaks, CA 91320, USA, Amgen Fremont Inc., One Amgen Center Drive, Thousand Oaks, CA 91320, USA → Amgen Fremont, Inc., One Amgen Center Drive, Thousand Oaks, CA 91320-1799, USA, Amgen Inc., One Amgen Center Drive, Thousand Oaks, CA 91320-1799, USA

    Published in Swissreg on 22.09.2021

  3. 30-05-2018

    Concedì

    Published in Swissreg on 30.05.2018

Partidas

Inventur

Boyle, William J.

Malibu, CA 90265, US

Martin, Francis H.

Newbury Park, CA 91320, US

Corvalan, Jose R.

Foster City, CA 94404, US

Davis, Geoffrey C.

Burlingame, CA 94010, US

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.